Paul Dietze | Burnet Institute

Professor Paul Dietze

Program Director, Disease Elimination; Professor and Program Leader, National Drug Research Institute (NDRI)

The relationship between naloxone dose and key patient variables in the treatment of non-fatal heroin overdose in the prehospital setting.

Cantwell K, Dietze P, Flander L

The relationship between naloxone dose and key patient variables in the treatment of non-fatal heroin overdose in the prehospital setting.

Effects of a sustained heroin shortage in three Australian States.

Degenhardt L, Day C, Dietze P, Pointer S, Conroy E, Collins L, Hall W

Effects of a sustained heroin shortage in three Australian States.

Transient changes in behaviour lead to heroin overdose: results from a case-crossover study of non-fatal overdose.

Dietze P, Jolley D, Fry C, Bammer G

Transient changes in behaviour lead to heroin overdose: results from a case-crossover study of non-fatal overdose.

Characteristics of non-fatal opioid overdoses attended by ambulance services in Australia.

Dietze P, Jolley D, Cvetkovski S, Cantwell K, Jacobs I, Indig D

Characteristics of non-fatal opioid overdoses attended by ambulance services in Australia.

Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose.

Kelly AM, Kerr D, Dietze P, Patrick I, Walker T, Koutsogiannis Z

Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose.

Initiation to heroin injecting among heroin users in Sydney, Australia: cross sectional survey.

Day CA, Ross J, Dietze P, Dolan K

Initiation to heroin injecting among heroin users in Sydney, Australia: cross sectional survey.

52
53
54
55
56
57

Subscribe to Burnet